- Sébastien Huron appointed Deputy CEO of Ceva Animal Health
- Move introduces dual leadership model with Executive Chairman role
- Marc Prikazsky shifts focus to long-term strategy and innovation
- Huron to lead global operations and chair Executive Committee
- Brings 30+ years of global animal health leadership experience
- Appointment supports next phase of growth and global expansion
Ceva Animal Health has announced the appointment of Sébastien Huron as Deputy Chief Executive Officer, marking a significant governance shift as the company adopts a dual leadership structure to support its continued global growth.
Under the new model, CEO Marc Prikazsky will transition to Executive Chairman, focusing on long-term strategy, innovation, and stakeholder relationships, while Huron will oversee day-to-day operations and lead the company’s Executive Committee.
“This governance evolution reflects the scale Ceva has reached and our ambition to reinforce both strategic focus and operational excellence,” said Prikazsky.
Driving Operational Leadership
In his new role, Huron will be responsible for managing Ceva’s global operations, bringing a strong track record in scaling organizations and driving commercial performance across multiple regions.
A trained veterinarian, Huron brings more than three decades of experience spanning marketing, R&D, and executive leadership roles across major animal health companies.
Extensive Global Experience
Huron’s career includes leadership positions at Mars, Hoechst Roussel Vet, Intervet, and Virbac, where he served as CEO from 2017 to 2024, leading a period of sustained growth.
His international experience across Europe, the Americas, and Asia has shaped his expertise in strategy, operations, and market development within the animal health sector.
Positioning for Future Growth
Ceva said the leadership change is designed to strengthen both strategic oversight and operational execution as the company continues to expand globally and address emerging challenges in animal health.
Huron emphasized his focus on supporting teams and accelerating growth, noting the company’s strong innovation culture and global footprint.
With more than 7,000 employees across 47 countries, Ceva continues to position itself as a major player in the global animal health market, spanning vaccines, pharmaceuticals, and animal welfare solutions.
Information sourced from the company’s press release.
